For the quarter ending 2026-03-31, MCS had -$12,228K decrease in cash & cash equivalents over the period. -$21,869K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Gain on insurance settlement | - | 0 | 4,535 | - |
| Impairment charges | - | 5,172 | 0 | 0 |
| Debt conversion expense | - | 0 | 0 | 0 |
| Net earnings (loss) | -15,353 | 5,956 | 16,230 | -9,495 |
| Losses on investments in joint ventures | -674 | -173 | 57 | -495 |
| Distribution from joint venture | 0 | 1 | 0 | 68 |
| Loss (gain) on disposition of property, equipment and other assets | -81 | -703 | 72 | 1,184 |
| Proceeds from sale of historic tax credits | 2,975 | - | - | - |
| Depreciation and amortization | 17,835 | 17,915 | 16,835 | 35,441 |
| Amortization of debt issuance costs | 140 | 140 | 150 | 314 |
| Share-based compensation | 3,824 | 1,286 | 1,230 | 4,986 |
| Deferred income taxes | -8,263 | -7,286 | 8,890 | -5,870 |
| Other long-term obligations | 1,093 | -252 | 571 | 181 |
| Contribution of the companys stock to savings and profit-sharing plan | - | 0 | - | - |
| Accounts receivable | -2,488 | -2,723 | -1,010 | 1,267 |
| Other assets | 550 | -111 | -3,228 | 6,437 |
| Operating leases | 693 | 552 | 528 | 1,053 |
| Accounts payable | -14,222 | 13,880 | -3,663 | -13,679 |
| Income taxes | 639 | -160 | -935 | 1,132 |
| Taxes other than income taxes | -3,515 | -336 | 306 | -204 |
| Accrued compensation | -6,075 | 2,708 | 4,111 | -8,233 |
| Other accrued liabilities | 3,701 | 6,618 | -3,682 | 1,116 |
| Total adjustments | 132 | 42,844 | 22,859 | 5,806 |
| Net cash used in operating activities | -15,221 | 48,800 | 39,089 | -3,689 |
| Capital expenditures | 6,648 | 22,402 | 20,894 | 39,915 |
| Proceeds from insurance settlement | - | 0 | 4,535 | - |
| Proceeds from disposals of property, equipment and other assets | 5 | -67 | 714 | 212 |
| Purchase of trading securities | - | 0 | 0 | 0 |
| Capital contribution in joint venture | - | 0 | 0 | 0 |
| Subscription and sale of joint venture interests | - | 0 | 0 | 0 |
| Proceeds from sale of trading securities | 0 | 0 | 0 | 8,187 |
| Other investing activities | -14 | 2,298 | -584 | 29 |
| Net cash used in investing activities | -6,629 | -24,767 | -15,061 | -31,545 |
| Proceeds from borrowings on revolving credit facility | 51,000 | 57,000 | 51,000 | 105,000 |
| Repayment of borrowings on revolving credit facility | 36,000 | 60,000 | 59,000 | 84,000 |
| Proceeds from issuance of long-term debt | - | 0 | 0 | - |
| Principal payments on long-term debt | 0 | 0 | 10,000 | 392 |
| Repayment of borrowing on insurance policy | - | 0 | - | - |
| Repurchase of convertible senior notes | - | 0 | 0 | 0 |
| Proceeds from capped call unwind | - | 0 | 0 | 0 |
| Debt issuance costs | - | 0 | 0 | - |
| Principal payments on finance lease obligations | 699 | 704 | 715 | 1,323 |
| Treasury stock transactions, except for stock options | -2,314 | -1,828 | -9,107 | -7,612 |
| Exercise of stock options | 45 | 1 | 4 | 10 |
| Dividends paid | 2,410 | 2,401 | 2,428 | 4,329 |
| Distributions to noncontrolling interest | - | 0 | - | - |
| Net cash provided by financing activities | 9,622 | -7,932 | -30,246 | 7,354 |
| Net decrease in cash, cash equivalents and restricted cash | -12,228 | 16,101 | -6,218 | -27,880 |
| Cash, cash equivalents and restricted cash at beginning of period | 26,582 | 10,481 | 44,579 | - |
| Cash, cash equivalents and restricted cash at end of period | 14,354 | 26,582 | 10,481 | - |
MARCUS CORP (MCS)
MARCUS CORP (MCS)